These findings were further confirmed in 2 new ER+ breast cancer cell lines derived from patient-derived xenografts (PDX), UCD4 and UCD65 (Additional file 1: S. Fig 4K, 4L). This evidence concerns the gene ESR1 and breast carcinoma.